The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
The Sirtuin 2 Inhibitor AK-7 Leads to an Antidepressant-Like Effect in Mice via Upregulation of CREB1, BDNF, and NTRK2 Pathways
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, it has been also proposed as an effective pharmacological option for the treatment of neuropsychiatric disorders such as depression (Guclu et al., 2022;Erburu et al., 2017;Zhang et al., 2018).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Guclu et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
BDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958 · cited 1×
“Increased CREB levels [45] and NTK2 expression [46, 47] are associated with antidepressant-like activity.”
BackgroundMolendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702 · cited 1×
“Various growth factors such as BDNF are known to be effective in neuroplasticity [36].”
BackgroundA negative regulator of MAP kinase causes depressive behavior
Duric, V., Banasr, M., Licznerski, P., Schmidt, H. D., Stockmeier, C. A., Simen, A. A., Newton, S. S., & Duman, R. S. (2010) · Nature Medicine · doi:10.1038/nm.2219 · Cited by 412
The Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365 · cited 1×
“Increased CREB levels [45] and NTK2 expression [46, 47] are associated with antidepressant-like activity.”
BackgroundThe Role of BDNF in Depression on the Basis of Its Location in the Neural Circuitry
Yu, H., & Chen, Z.-Y. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.184 · Cited by 343
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308 · cited 1×
“Decrement in the neurotrophic factors and the level of neuroplasticity are one of the significant mechanisms of depression [33].”
BackgroundFrom Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
Liu, B., Liu, J., Wang, M., Zhang, Y., & Li, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00305 · Cited by 249 · cited 1×
“As it is well identified, the adaptation of neurons and neural elements to internal and external signals is defined as neuroplasticity [34].”
BackgroundSIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens
Kim, H.-D., Hesterman, J., Call, T., Magazu, S., Keeley, E., Armenta, K., Kronman, H., Neve, R. L., Nestler, E. J., & Ferguson, D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0212-16.2016 · Cited by 158
Role and possible mechanisms of Sirt1 in depression
Lu, G., Li, J., Zhang, H., Zhao, X., Yan, L.-J., & Yang, X. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8596903 · Cited by 106
Research works printed but not linked: 36
- Sobocki P, Jönsson B, Angst J, Rehnberg C (2006) Cost of depression in Europe. J Ment Health Policy Econ 9(2):87–98
- Misztak P, Pańczyszyn-Trzewik P, Sowa-Kućma M (2018) Histone deacetylases (HDACs) as therapeutic target for depressive disorders. Pharmacol Rep 70(2):398–408 · DOI
- Ionescu DF, Rosenbaum JF, Alpert EA (2015) Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues Clin Neurosci 17:111–126 · DOI · Paper page
- Goto S, Terao T, Hoaki N, Wang Y, Tsuchiyama K, Araki Y, Kohno K (2012) Is serotonergic function associated with the antidepressant effects of modified-electroconvulsive therapy? J Affect Disord 136(3):1062–1066 · DOI
- Kaeberlein M, McVey M, Guarente L (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13(19):2570–2580 · DOI · Paper page
- Michan S, Sinclair D (2007) Sirtuins in mammals: insights into their biological function. Biochem J 404(1):1–13 · DOI · Paper page
- Chandramowlishwaran P, Vijay A, Abraham D, Li G, Mwangi SM, Srinivasan S (2020) Role of sirtuins in modulating neurodegeneration of the enteric nervous system and central nervous system. Front Neurosci 14:614331 · DOI
- Yeong KY, Berdigaliyev N, Chang Y (2020) Sirtuins and their implications in neurodegenerative diseases from a drug discovery perspective. ACS Chem Neurosci 11(24):4073–4091 · DOI
- Zhang Y, Anoopkumar-Dukie S, Arora D, Davey AK (2020) Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases. Eur J Pharmacol 867:172847 · DOI
- Biella G, Fusco F, Nardo E, Bernocchi O, Colombo A, Lichtenthaler SF, Forloni G, Albani D (2016) Sirtuin 2 inhibition improves cognitive performance and acts on amyloid-β protein precursor processing in two Alzheimer’s disease mouse models. J Alzheimers Dis 53(3):1193–1207 · DOI · Paper page
- Chen X, Wales P, Quinti L, Zuo F, Moniot S, Herisson F, Rauf NA, Wang H, Silverman RB, Ayata C, Maxwell MM, Steegborn C, Schwarzschild MA, Outeiro TF, Kazantsev AG (2015) The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson’s disease but not amyotrophic lateral sclerosis and cerebral ischemia. PLoS ONE 10(1):e0116919 · DOI
- Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, Cipicchio PM, Lauver MA, Choi SH, Silverman RB, Ferrante RJ, Hersch S, Kazantsev AG (2012) The sirtuin 2 inhibitor AK7 is neuroprotective in Huntington’s disease mouse models. Cell Rep 2(6):1492–1497 · DOI · Paper page
- Ferland CL, Hawley WR, Puckett RE, Wineberg K, Lubin FD, Dohanich GP, Schrader LA (2013) Sirtuin activity in dentate gyrus contributes to chronic stress-induced behavior and extracellular signal-regulated protein kinases 1 and 2 cascade changes in the hippocampus. Biol Psychiatry 74:927–935 · DOI
- Erburu M, Muñoz-Cobo I, Diaz-Perdigon T, Mellini P, Suzuki T, Puerta E, Tordera RM (2017) SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action. Neuropharmacology 117:195–208 · DOI · Paper page
- Duan CM, Zhang JR, Wan TF, Wang Y, Chen HS, Liu L (2020) SRT2104 attenuates chronic unpredictable mild stress-induced depressive-like behaviors and imbalance between microglial M1 and M2 phenotypes in the mice. Behav Brain Res 378:112296 · DOI
- Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732 · DOI · Paper page
- Inan SY, Yalcin I, Aksu F (2004) Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol Biochem Behav 77(3):457–464 · doi:10.1016/j.pbb.2003.12.024
- Inan SY, Soner BC, Sahin AS (2016) Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson’s disease. Metab Brain Dis 31(4):849–857 · DOI
- Inan SY, Aksu F (2002) Amnesic effects of relative humidity and temperature in mice. Lab Anim 31(2):40–48
- Venzala E, García-García AL, Elizalde N, Delagrange P, Tordera RM (2012) Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors. Psychopharmacology 224(2):313–325 · DOI · Paper page
- Maurissen JP, Marable BR, Andrus AK, Stebbins KE (2003) Factors affecting grip strength testing. Neurotoxicol Teratol 25(5):543–553 · doi:10.1016/s0892-0362(03)00073-4
- Jung HY, Yoo DY, Kim JW, Kim DW, Choi JH, Chung JY, Won MH, Yoon YS, Hwang IK (2016) Sirtuin-2 inhibition affects hippocampal functions and sodium butyrate ameliorates the reduction in novel object memory, cell proliferation, and neuroblast differentiation. Lab Anim Res 32(4):224–230 · DOI
- Yuan F, Xu ZM, Lu LY, Nie H, Ding J, Ying WH, Tian HL (2016) SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation. J Neurochem 136(3):581–593 · DOI
- Li D, Wang Y, Jin X, Hu D, Xia C, Xu H, Hu J (2020) NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice. J Neuroinflammation 17(1):126 · DOI · Paper page
- Du X, Yin M, Yuan L, Zhang G, Fan Y, Li Z, Yuan N, Lv X, Zhao X, Zou S, Deng W, Kosten TR, Zhang XY (2020) Reduction of depression-like behavior in rat model induced by ShRNA targeting norepinephrine transporter in locus coeruleus. Transl Psychiatry 10(1):130 · DOI
- Erburu M, Muñoz-Cobo I, Domínguez-Andrés J, Beltran E, Suzuki T, Mai A, Valente S, Puerta E, Tordera RM (2015) Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity. Eur Neuropsychopharmacol 25(11):2036–2048 · DOI
- Malhi GS, Morris G, Bell E, Hamilton A (2020) A new paradigm for achieving a rapid antidepressant response. Drugs 80(8):755–764 · DOI
- Jesulola E, Micalos P, Baguley IJ (2018) Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model—are we there yet? Behav Brain Res 341:79–90 · DOI · Paper page
- Serafini G (2012) Neuroplasticity and major depression, the role of modern antidepressant drugs. World J Psychiatry 2(3):49–57 · DOI
- Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22(8):3251–3261 · DOI · Paper page
- Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77(3):916–928 · DOI · Paper page
- Neve RL, Finch EA, Bird ED, Benowitz LI (1988) Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc Natl Acad Sci USA 85(10):3638–3642 · DOI · Paper page
- De la Monte SM, Federoff HJ, Ng SC, Grabczyk E, Fishman MC (1989) GAP-43 gene expression during development: persistence in a distinctive set of neurons in the mature central nervous system. Brain Res Dev Brain Res 46(2):161–168 · DOI · Paper page
- Han MH, Jiao S, Jia JM, Chen Y, Chen CY, Gucek M, Markey SP, Li Z (2013) The novel caspase-3 substrate Gap43 is involved in AMPA receptor endocytosis and long-term depression. Mol Cell Proteomics 12(12):3719–3731 · DOI · Paper page
- Nibuya M, Nestler EJ, Duman RS (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16(7):2365–2372 · DOI · Paper page
- Trautmann C, Bock A, Urbach A, Hübner CA, Engmann O (2020) Acute vitamin B12 supplementation evokes antidepressant response and alters Ntrk-2. Neuropharmacology 171:108112 · DOI
Cited by
Dhiman, S., Mannan, A., Taneja, A., Mohan, M., & Singh, T. G. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122537 · Cited by 25
Sola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Metadata
- Authors
- Guclu, E., Inan, S. Y., & Vural, H. C.
- ORCID
- Inan, Salim Yalcin
- Venue
- Molecular Neurobiology
- Published
- 2022-09-08
- Volume
- 59
- Issue
- 11
- Pages
- 7036-7044
- ISSN
- 0893-7648
- 1559-1182
- Cited by
- 21
- References
- 11
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Funders
- University of Konya-NE (191218013)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Sirtuin 2 Inhibitor AK-7 Leads to an Antidepressant-Like Effect in Mice via Upregulation of CREB1, BDNF, and NTRK2 Pathways. https://app.cochat.ai/papers/10.1007/s12035-022-03026-8
- The paper
- Guclu, E., Inan, S. Y., & Vural, H. C. (2022). The Sirtuin 2 Inhibitor AK-7 Leads to an Antidepressant-Like Effect in Mice via Upregulation of CREB1, BDNF, and NTRK2 Pathways. Molecular Neurobiology. https://doi.org/10.1007/s12035-022-03026-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.